Qunyi Li

4PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 10, 2026
Immune checkpoint inhibitor-based first-line therapies for advanced or unresectable hepatocellular carcinoma: a network meta-analysis and cost-effectiveness analysis.

Huijie Qi, Yuxin Huang, Wenxin Zhang

|Jul 02, 2025
DNMBP-AS1/hsa-miR-30a-5p/PGC1α axis suppresses tumor progression of colorectal cancer by inhibiting PKM2-mediated Warburg effect and enhance anti-PD-1 therapy efficacy.

Tianxiao Wang, Wenxin Zhang, Jiafeng Liu

|May 23, 2025
VSIG4 Promotes Tumour-Associated Macrophage M2 Polarization and Immune Escape in Colorectal Cancer via Fatty Acid Oxidation Pathway.

|May 24, 2024
Nur77-IRF1 axis inhibits esophageal squamous cell carcinoma growth and improves anti-PD-1 treatment efficacy.

Huanying Shi, Lu Chen, Tianxiao Wang

Pageof 1

Frequent Collaborators

2 joint publications

Huanying Shi

2 joint publications

Haifei Chen

1 joint publications

Yongjun Zhu

1 joint publications

Tianxiao Wang